Mindanao State University - Iligan Institute of Technology Student: EGAO, Vanessa Jones C. - Section:260
Mindanao State University - Iligan Institute of Technology Student: EGAO, Vanessa Jones C. - Section:260
Mindanao State University - Iligan Institute of Technology Student: EGAO, Vanessa Jones C. - Section:260
___Section:260___
PHARMACOLOGY
DRUG STUDY
Brand Name: Methergine_______________ Generic Name: Methylergonovine Maleate Drug Classification: Adrenergic Antagonist (Sympatholytic); Ergot Alkaloid; Oxytocic
Responsibilities in the Nursing Process (ADPIE) Responsibilities in the Nursing Process (ADPIE)
Assessment Intervention:
Monitor vital signs (particularly BP) and uterine response during and after parenteral administration of Report severe cramping for increased bleeding.
methylergonovine until partum period is stabilized (about 1–2 h). Report any of the following: Cold or numb fingers or toes, nausea or vomiting, chest or
Notify physician if BP suddenly increases or if there are frequent periods of uterine relaxation. muscle pain.
Assess skin and mucous membranes for signs of petechiae, bruising, hematoma formation, or oozing of blood. Do not breast feed while taking this drug
Educate the at-risk patient about precautionary measures to prevent tissue trauma or
Nursing Diagnosis: disruption of the normal clotting mechanisms.
Risk for Bleeding Educate the patient and family members about signs of bleeding that need to be
reported to a health care provider.
Planning:
After 2 days of nursing intervention, the client does not experience bleeding as evidenced by normal blood pressure, Evaluation:
stable hematocrit and hemoglobin levels and desired ranges for coagulation profiles. After 2 days of nursing intervention, the client did not experience bleeding as
evidenced by normal blood pressure, stable hematocrit and hemoglobin levels and
desired ranges for coagulation profiles.